Pemetrexed in the treatment of relapsed/refractory primary central nervous system lymphoma
Cancer, 05/02/2012
Raizer JJ et al. – Pemetrexed has single–agent activity in relapsed/refractory primary central nervous system lymphoma (PCNSL). Toxicities were seen likely because of the higher than standard dose used.



